Senti Biosciences Overview
Latest PEG ratio for Senti Biosciences: 1.34 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow1.34
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Senti Biosciences's peg ratio stands at 1.34. That is below the sector sector average of 3.69. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Senti Biosciences sits lower the its sector benchmark (3.69) with a PEG ratio of 1.34. That is roughly 63.6% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 1.34 is attractive depends on Senti Biosciences's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Senti Biosciences's PEG ratio evolved across reporting periods, while the comparison chart places SNTI next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
